Neuberger Berman Group LLC Merck & Co., Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 5,524,307 shares of MRK stock, worth $684 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

5,524,307

Holding current value

$684 Million

% of portfolio

0.62%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $626 Million - $729 Million	5,524,307 New	5,524,307 $729 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $50.4 Million - $54.9 Million	-503,156 Reduced 7.42%	6,277,158 $684 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $11.9 Million - $13.2 Million	115,761 Added 1.74%	6,780,314 $698 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $2.35 Million - $2.56 Million	21,598 Added 0.33%	6,664,553 $769 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $92 Million - $103 Million	893,583 Added 15.54%	6,642,955 $707 Million

Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $7.95 Million - $10.2 Million	-90,941 Reduced 1.56%	5,749,372 $638 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $160 Million - $180 Million	1,897,517 Added 48.13%	5,840,313 $503 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $62.1 Million - $70.4 Million	743,969 Added 23.26%	3,942,796 $360 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $49.4 Million - $55.3 Million	671,679 Added 26.58%	3,198,827 $259 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $144 Million - $181 Million	1,995,842 Added 375.65%	2,527,148 $191 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $349,153 - $383,980	-4,871 Reduced 0.91%	531,306 $38 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $110,597 - $122,332	-1,573 Reduced 0.29%	536,177 $40 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $2.66 Million - $3.14 Million	-38,671 Reduced 6.71%	537,750 $41 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $309,687 - $343,689	4,315 Added 0.75%	576,421 $46.9 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $4.02 Million - $4.55 Million	-54,867 Reduced 8.75%	572,106 $45.3 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $1.82 Million - $2.07 Million	-25,870 Reduced 3.96%	626,973 $48.4 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $2.67 Million - $3.7 Million	-42,087 Reduced 6.06%	652,843 $47.9 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $15.2 Million - $17.2 Million	-196,140 Reduced 22.01%	694,930 $63.2 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $13 Million - $14.2 Million	-171,214 Reduced 16.12%	891,070 $75 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $144,638 - $168,972	-2,071 Reduced 0.19%	1,062,284 $89.1 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $222,029 - $253,237	-3,191 Reduced 0.3%	1,064,355 $88.5 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $3.11 Million - $3.61 Million	-47,678 Reduced 4.28%	1,067,546 $81.6 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $4.85 Million - $5.71 Million	84,135 Added 8.16%	1,115,224 $79.1 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $16.3 Million - $19.2 Million	321,547 Added 45.32%	1,031,089 $62.7 Million
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $11 Million - $12.8 Million	-216,361 Reduced 23.37%	709,542 $38.7 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $45.8 Million - $54.6 Million	-886,492 Reduced 48.91%	925,903 $52.2 Million
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $106 Million - $114 Million	1,812,395	1,812,395 $116 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Merck & Co., Inc. Transaction History